Osimertinib vs Sitagliptin
Osimertinib vs Sitagliptin: Overview
This comparison examines the pharmacological differences between Osimertinib and Sitagliptin.
Mechanism of Action
Osimertinib: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.
Sitagliptin: DPP-4 inhibitor increasing incretin levels.
Pharmacokinetics
Half-life: Osimertinib — 48 hours; Sitagliptin — 12.4 hours.
Chemical Properties
Molecular Formula: Osimertinib — C28H33N7O2; Sitagliptin — C16H15F6N5O.
Molecular Weight: Osimertinib — 499.6050 g/mol; Sitagliptin — 407.3140 g/mol.
Type: Osimertinib — Small molecule; Sitagliptin — Small molecule.